| Hilde Almåsbak | |
| Position: | PhD student |
| Phone: | +47 22781307 |
| Email: | |
CV
Employment
August 2007- PhD student, Section for Immunology, Oslo University Hospital- Radiumhospitalet.
Project: Chimeric T cells for treatment of paediatric cancers, CHILDHOPE
2001-2007 Scientist / Senior Scientist, Dynal Invitrogen, Oslo
1986-2000 Analytical Chemist / Senior Engineer in pharmaceutical and biotech industry
(Nycomed Imaging / Amersham, Dynal)
Degree
2000-2004 MSc, Department of Molecular Biosciences, University of Oslo
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
Patents US Title: MAGNETIC SEPARATOR. Abstract: A magnetic separator unit for the selective separation of at least one component from a fluid mixture is described. The unit can include at least one mandrel-shaped magnet unit and tubing wrapped around it. Fluid containing magnetisable particles can be passed through the tubing to allow attraction of the particles to the magnet unit. Inventors:ALMAASBAK, Hilde; (NO).Johansson Christer (SE); Pub. No.: WO/2007/063529 International Application No.: PCT/IB2006/054564Publication Date:07.06.2007. Applicants:INVITROGEN DYNAL AS
Author network for Hilde Almåsbak by COREMINE medical
Publications 2011
Transiently redirected T cells for adoptive transfer
Cytotherapy, 13 (5), 629-40
PubMed 21174490
Publications 2010
Non-MHC-dependent redirected T cells against tumor cells
Methods Mol Biol, 629, 453-93
PubMed 20387166
Publications 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
J Immunol Methods, 283 (1-2), 125-39
PubMed 14659905
Go back
Print this page
E-mail this page
